MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.42
(0.0%)
EUR 2.42
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 364.53 Million EUR | -12.08% |
| 2022 | 414.63 Million EUR | 29.39% |
| 2021 | 320.44 Million EUR | -17.1% |
| 2020 | 386.53 Million EUR | -18.65% |
| 2019 | 475.13 Million EUR | 1028.95% |
| 2018 | 42.08 Million EUR | 52.74% |
| 2017 | 27.55 Million EUR | 90.48% |
| 2016 | 14.46 Million EUR | -40.78% |
| 2015 | 24.42 Million EUR | -29.01% |
| 2014 | 34.4 Million EUR | -36.19% |
| 2013 | 53.91 Million EUR | 3.0% |
| 2012 | 52.35 Million EUR | 7.54% |
| 2011 | 48.68 Million EUR | 22.68% |
| 2010 | 39.68 Million EUR | 61.36% |
| 2009 | 24.59 Million EUR | -34.68% |
| 2008 | 37.65 Million EUR | 276.13% |
| 2007 | -21.37 Million EUR | 26.44% |
| 2006 | -29.06 Million EUR | -7.68% |
| 2005 | -26.99 Million EUR | -49.48% |
| 2004 | -18.05 Million EUR | 22.79% |
| 2003 | -23.38 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 363.12 Million EUR | 2.15% |
| 2024 Q1 | 355.49 Million EUR | -2.48% |
| 2023 Q2 | 401.72 Million EUR | -1.45% |
| 2023 Q1 | 407.63 Million EUR | -1.69% |
| 2023 Q3 | 376.49 Million EUR | -6.28% |
| 2023 Q4 | 364.53 Million EUR | -3.18% |
| 2023 FY | 364.53 Million EUR | -12.08% |
| 2022 Q2 | 321.13 Million EUR | 1.1% |
| 2022 Q4 | 414.63 Million EUR | 35.56% |
| 2022 FY | 414.63 Million EUR | 29.39% |
| 2022 Q3 | 305.87 Million EUR | -4.75% |
| 2022 Q1 | 317.63 Million EUR | -0.88% |
| 2021 Q1 | 374.59 Million EUR | -3.09% |
| 2021 Q4 | 320.44 Million EUR | -5.76% |
| 2021 Q2 | 368.15 Million EUR | -1.72% |
| 2021 Q3 | 340.02 Million EUR | -7.64% |
| 2021 FY | 320.44 Million EUR | -17.1% |
| 2020 Q3 | 401 Million EUR | -8.47% |
| 2020 Q2 | 438.11 Million EUR | -8.48% |
| 2020 FY | 386.53 Million EUR | -18.65% |
| 2020 Q1 | 478.7 Million EUR | 0.75% |
| 2020 Q4 | 386.53 Million EUR | -3.61% |
| 2019 Q3 | 478.68 Million EUR | -3.24% |
| 2019 Q2 | 494.71 Million EUR | -0.17% |
| 2019 Q1 | 495.57 Million EUR | 1077.51% |
| 2019 FY | 475.13 Million EUR | 1028.95% |
| 2019 Q4 | 475.13 Million EUR | -0.74% |
| 2018 Q1 | 30.25 Million EUR | 9.8% |
| 2018 FY | 42.08 Million EUR | 52.74% |
| 2018 Q4 | 42.08 Million EUR | 17.05% |
| 2018 Q3 | 35.95 Million EUR | -13.63% |
| 2018 Q2 | 41.63 Million EUR | 37.6% |
| 2017 Q2 | 32.9 Million EUR | 36.51% |
| 2017 Q3 | 26.25 Million EUR | -20.22% |
| 2017 Q4 | 27.55 Million EUR | 4.97% |
| 2017 Q1 | 24.1 Million EUR | 66.61% |
| 2017 FY | 27.55 Million EUR | 90.48% |
| 2016 Q2 | 28.77 Million EUR | 12.52% |
| 2016 FY | 14.46 Million EUR | -40.78% |
| 2016 Q3 | 15.47 Million EUR | -46.22% |
| 2016 Q1 | 25.57 Million EUR | 4.7% |
| 2016 Q4 | 14.46 Million EUR | -6.54% |
| 2015 Q4 | 24.42 Million EUR | 48.19% |
| 2015 Q3 | 16.48 Million EUR | -48.11% |
| 2015 Q1 | 27.68 Million EUR | -19.55% |
| 2015 Q2 | 31.76 Million EUR | 14.75% |
| 2015 FY | 24.42 Million EUR | -29.01% |
| 2014 Q2 | 44.56 Million EUR | -0.93% |
| 2014 Q3 | 28.39 Million EUR | -36.3% |
| 2014 Q1 | 44.98 Million EUR | -16.57% |
| 2014 Q4 | 34.4 Million EUR | 21.2% |
| 2014 FY | 34.4 Million EUR | -36.19% |
| 2013 Q4 | 53.91 Million EUR | 25.75% |
| 2013 Q2 | 53.01 Million EUR | -0.2% |
| 2013 Q1 | 53.11 Million EUR | 1.46% |
| 2013 FY | 53.91 Million EUR | 3.0% |
| 2013 Q3 | 42.87 Million EUR | -19.12% |
| 2012 FY | 52.35 Million EUR | 7.54% |
| 2012 Q3 | 40.32 Million EUR | -13.46% |
| 2012 Q1 | 50.41 Million EUR | 3.55% |
| 2012 Q4 | 52.35 Million EUR | 29.81% |
| 2012 Q2 | 46.6 Million EUR | -7.56% |
| 2011 Q1 | 37.11 Million EUR | -6.47% |
| 2011 Q2 | 47.09 Million EUR | 26.88% |
| 2011 Q3 | 45.29 Million EUR | -3.81% |
| 2011 Q4 | 48.68 Million EUR | 7.47% |
| 2011 FY | 48.68 Million EUR | 22.68% |
| 2010 Q3 | 36.26 Million EUR | -17.33% |
| 2010 Q4 | 39.68 Million EUR | 9.41% |
| 2010 Q2 | 43.87 Million EUR | 13.49% |
| 2010 Q1 | 38.65 Million EUR | 57.18% |
| 2010 FY | 39.68 Million EUR | 61.36% |
| 2009 Q4 | 24.59 Million EUR | 0.0% |
| 2009 FY | 24.59 Million EUR | -34.68% |
| 2008 FY | 37.65 Million EUR | 276.13% |
| 2007 FY | -21.37 Million EUR | 26.44% |
| 2006 FY | -29.06 Million EUR | -7.68% |
| 2005 FY | -26.99 Million EUR | -49.48% |
| 2004 FY | -18.05 Million EUR | 22.79% |
| 2003 FY | -23.38 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 10.64 Billion EUR | 96.576% |
| Fresenius SE & Co. KGaA | 13.54 Billion EUR | 97.308% |
| LIMES Schlosskliniken AG | 1.57 Million EUR | -23101.856% |
| M1 Kliniken AG | -5.33 Million EUR | 6930.792% |
| Maternus-Kliniken Aktiengesellschaft | 111.79 Million EUR | -226.066% |
| RHÖN-KLINIKUM Aktiengesellschaft | -56.2 Million EUR | 748.587% |
| VITA 34 AG | 4.15 Million EUR | -8665.052% |